Sugi Predict

Sugi Predict / Compounds / SCHEMBL2283008

SCHEMBL2283008

SCHEMBL2283008

Cc1nnc2c3cc(-c4ccccc4)c(-c4ccc(CNC(=O)Cc5ccccn5)cc4)nc3ccn12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 8/20 0.51
▸ AKT2 P31751 8/20 0.51
▸ KCNH2 Q12809 4/20 0.51
▸ HDAC1 Q13547 2/20 0.45
▸ POLB P06746 1/20 0.39
▸ HPGD P15428 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ NAMPT P43490 1/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ MAPT P10636 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ CYP3A4 P08684 1/20 0.38
▸ PTGFR P43088 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2279950 0.91 AKT1 (0.46) AKT1AKT2KCNH2HDAC1LMNA
SCHEMBL2279249 0.91 ALDH1A1 (0.47) AKT1AKT2KCNH2LMNAALDH1A1
SCHEMBL2279645 0.89 AKT1 (0.47) AKT1AKT2KCNH2HDAC1LMNA
SCHEMBL2281677 0.89 AKT1 (0.46) AKT1AKT2KCNH2HPGDLMNA
SCHEMBL2278868 0.89 AKT1 (0.48) AKT1AKT2KCNH2POLBHPGD
SCHEMBL2276480 0.88 AKT1 (0.43) AKT1AKT2KCNH2HPGDLMNA
SCHEMBL2280049 0.88 AKT1 (0.45) AKT1AKT2KCNH2HPGDLMNA
SCHEMBL3504691 0.87 AKT1 (0.47) AKT1AKT2KCNH2HPGDLMNA
SCHEMBL2287763 0.87 AKT1 (0.47) AKT1AKT2KCNH2HPGDLMNA
SCHEMBL2277096 0.87 LMNA (0.50) AKT1AKT2KCNH2HDAC1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1898903-B1 INHIBITORS OF AKT ACTIVITY MERCK SHARP & DOHME (US) 2013-03-27 — — EP claimed
US-8008317-B2 Inhibitors of akt activtiy MERCK SHARP & DOHME CORP. (US) 2011-08-30 — — US claimed
US-20100222321-A1 Inhibitors of akt activtiy MERCK SHARP & DOHME LLC 2010-09-02 — — US claimed
EP-1898903-B1 INHIBITORS OF AKT ACTIVITY MERCK SHARP & DOHME (US) 2013-03-27 — — EP disclosed
US-8008317-B2 Inhibitors of akt activtiy MERCK SHARP & DOHME CORP. (US) 2011-08-30 — — US disclosed
US-8008317-B2 Inhibitors of akt activtiy MERCK SHARP & DOHME CORP. (US) 2011-08-30 — — US disclosed
US-8008317-B2 Inhibitors of akt activtiy MERCK SHARP & DOHME CORP. (US) 2011-08-30 — — US disclosed
US-20100222321-A1 Inhibitors of akt activtiy MERCK SHARP & DOHME LLC 2010-09-02 — — US disclosed
US-20100222321-A1 Inhibitors of akt activtiy MERCK SHARP & DOHME LLC 2010-09-02 — — US disclosed
US-20100222321-A1 Inhibitors of akt activtiy MERCK SHARP & DOHME LLC 2010-09-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222321-A1 Inhibitors of akt activtiy PIK3CA, PIK3CD, INPP5D AKT1 8/4885AKT2 4/4885KCNH2 3672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.